Market openNon-fractional
Perspective Therapeutics/CATX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Perspective Therapeutics
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Ticker
CATX
Sector
Healthcare
Trading on
AMEX
Industry
Biotechnology
Headquarters
Seattle, United States
Employees
118
CATX Metrics
BasicAdvanced
$725M
Market cap
-
P/E ratio
-$1.75
EPS
1.43
Beta
-
Dividend rate
Price and volume
Market cap
$725M
Beta
1.43
Financial strength
Current ratio
12.977
Quick ratio
12.525
Long term debt to equity
1.174
Total debt to equity
1.252
Interest coverage (TTM)
-391.21%
Management effectiveness
Return on assets (TTM)
-13.61%
Return on equity (TTM)
-28.96%
Valuation
Price to revenue (TTM)
235.482
Price to book
2.76
Price to tangible book (TTM)
4.07
Price to free cash flow (TTM)
-15.432
Growth
Revenue change (TTM)
-44.27%
Earnings per share change (TTM)
192.43%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Perspective Therapeutics stock?
Perspective Therapeutics (CATX) has a market cap of $725M as of July 05, 2024.
What is the P/E ratio for Perspective Therapeutics stock?
The price to earnings (P/E) ratio for Perspective Therapeutics (CATX) stock is 0 as of July 05, 2024.
Does Perspective Therapeutics stock pay dividends?
No, Perspective Therapeutics (CATX) stock does not pay dividends to its shareholders as of July 05, 2024.
When is the next Perspective Therapeutics dividend payment date?
Perspective Therapeutics (CATX) stock does not pay dividends to its shareholders.
What is the beta indicator for Perspective Therapeutics?
Perspective Therapeutics (CATX) has a beta rating of 1.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Perspective Therapeutics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.